Zilver PTX Post-market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 2-Year Results View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-11-08

AUTHORS

Kimihiko Kichikawa, Shigeo Ichihashi, Hiroyoshi Yokoi, Takao Ohki, Masato Nakamura, Kimihiro Komori, Shinsuke Nanto, Erin E. O’Leary, Aaron E. Lottes, Scott A. Snyder, Michael D. Dake

ABSTRACT

PurposeA prospective, multicenter post-market surveillance study in Japan evaluated the 2-year safety and effectiveness of the DES in real-world patients with complex femoropopliteal artery lesions.MethodsThere were no exclusion criteria, and consecutive symptomatic patients with femoropopliteal lesions treated with the DES were enrolled in the study. Clinically driven target lesion revascularization (TLR) was defined as reintervention performed for > 50% diameter stenosis after recurrent clinical symptoms of peripheral arterial disease. Clinical benefit was defined as freedom from persistent or deteriorating ischemic symptoms. Patency was evaluated by duplex ultrasound where physicians considered this standard of care.ResultsIn this study, 905 patients were enrolled at 95 institutions in Japan. There were numerous comorbidities including a high incidence of diabetes (58.8%) and chronic kidney disease (43.6%). Additionally, 21.4% of patients were classified with critical limb ischemia. Lesions were complex, with an average length of 14.6 ± 9.6 cm (range 0.5–40 cm), 41.5% total occlusions, and 18.7% in-stent restenosis. In total, 1861 DES were placed in 1080 lesions. Two-year follow-up was obtained for > 90% of eligible patients. Freedom from TLR was 83.7%, and clinical benefit was 80.0% through 2 years. The 2-year primary patency rate was 70.3%. Rutherford classification significantly improved (p < 0.01), with approximately 80% of patients classified as Rutherford class 0 or 1 at 2 years.ConclusionDespite more challenging lesion characteristics, 2-year results from the current study are similar to outcomes from the previous Zilver PTX studies, confirming the efficacy of the Zilver PTX DES in a complicated femoropopliteal lesion (Zilver PTX Post-Market Study in Japan; NCT02254837).Level of EvidencePost-market surveillance study, Level III. More... »

PAGES

358-364

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00270-018-2110-1

DOI

http://dx.doi.org/10.1007/s00270-018-2110-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1109785132

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30411151


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug-Eluting Stents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Femoral Artery", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Japan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Paclitaxel", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Peripheral Arterial Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Popliteal Artery", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tubulin Modulators", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ultrasonography, Doppler, Duplex", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vascular Patency", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Radiology, Nara Medical University, Kashihara, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410814.8", 
          "name": [
            "Department of Radiology, Nara Medical University, Kashihara, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kichikawa", 
        "givenName": "Kimihiko", 
        "id": "sg:person.0745745646.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0745745646.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiology, Nara Medical University, Kashihara, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410814.8", 
          "name": [
            "Department of Radiology, Nara Medical University, Kashihara, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ichihashi", 
        "givenName": "Shigeo", 
        "id": "sg:person.01322045470.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322045470.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, Fukuoka Sanno Hospital, Fukuoka, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Cardiovascular Medicine, Fukuoka Sanno Hospital, Fukuoka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yokoi", 
        "givenName": "Hiroyoshi", 
        "id": "sg:person.01052603744.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01052603744.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Jikei University Hospital, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.470100.2", 
          "name": [
            "Department of Surgery, Jikei University Hospital, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ohki", 
        "givenName": "Takao", 
        "id": "sg:person.0623364450.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623364450.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cardiovascular Medicine, Ohashi Medical Center, Toho University, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.265050.4", 
          "name": [
            "Division of Cardiovascular Medicine, Ohashi Medical Center, Toho University, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakamura", 
        "givenName": "Masato", 
        "id": "sg:person.01031752616.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031752616.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Vascular Surgery, Division of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan", 
          "id": "http://www.grid.ac/institutes/grid.27476.30", 
          "name": [
            "Division of Vascular Surgery, Division of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Komori", 
        "givenName": "Kimihiro", 
        "id": "sg:person.01271562423.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271562423.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nishinomiya Hospital Affairs, Nishinomiya Municipal Central Hospital, Nishinomiya, Japan", 
          "id": "http://www.grid.ac/institutes/grid.416305.5", 
          "name": [
            "Nishinomiya Hospital Affairs, Nishinomiya Municipal Central Hospital, Nishinomiya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nanto", 
        "givenName": "Shinsuke", 
        "id": "sg:person.01311264335.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311264335.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cook Research Incorporated, West Lafayette, IN, USA", 
          "id": "http://www.grid.ac/institutes/grid.510407.7", 
          "name": [
            "Cook Research Incorporated, West Lafayette, IN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "O\u2019Leary", 
        "givenName": "Erin E.", 
        "id": "sg:person.0672625424.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0672625424.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cook Research Incorporated, West Lafayette, IN, USA", 
          "id": "http://www.grid.ac/institutes/grid.510407.7", 
          "name": [
            "Cook Research Incorporated, West Lafayette, IN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lottes", 
        "givenName": "Aaron E.", 
        "id": "sg:person.01074671261.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01074671261.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cook Research Incorporated, West Lafayette, IN, USA", 
          "id": "http://www.grid.ac/institutes/grid.510407.7", 
          "name": [
            "Cook Research Incorporated, West Lafayette, IN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Snyder", 
        "givenName": "Scott A.", 
        "id": "sg:person.0624512224.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624512224.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiothoracic Surgery, Stanford University Medical Center, Stanford, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.240952.8", 
          "name": [
            "Department of Cardiothoracic Surgery, Stanford University Medical Center, Stanford, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dake", 
        "givenName": "Michael D.", 
        "id": "sg:person.0641462234.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0641462234.03"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00270-017-1673-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085377186", 
          "https://doi.org/10.1007/s00270-017-1673-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12928-014-0287-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005096819", 
          "https://doi.org/10.1007/s12928-014-0287-z"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-11-08", 
    "datePublishedReg": "2018-11-08", 
    "description": "PurposeA prospective, multicenter post-market surveillance study in Japan evaluated the 2-year safety and effectiveness of the DES in real-world patients with complex femoropopliteal artery lesions.MethodsThere were no exclusion criteria, and consecutive symptomatic patients with femoropopliteal lesions treated with the DES were enrolled in the study. Clinically driven target lesion revascularization (TLR) was defined as reintervention performed for\u2009>\u200950% diameter stenosis after recurrent clinical symptoms of peripheral arterial disease. Clinical benefit was defined as freedom from persistent or deteriorating ischemic symptoms. Patency was evaluated by duplex ultrasound where physicians considered this standard of care.ResultsIn this study, 905 patients were enrolled at 95 institutions in Japan. There were numerous comorbidities including a high incidence of diabetes (58.8%) and chronic kidney disease (43.6%). Additionally, 21.4% of patients were classified with critical limb ischemia. Lesions were complex, with an average length of 14.6\u2009\u00b1\u20099.6\u00a0cm (range 0.5\u201340\u00a0cm), 41.5% total occlusions, and 18.7% in-stent restenosis. In total, 1861 DES were placed in 1080 lesions. Two-year follow-up was obtained for\u2009>\u200990% of eligible patients. Freedom from TLR was 83.7%, and clinical benefit was 80.0% through 2\u00a0years. The 2-year primary patency rate was 70.3%. Rutherford classification significantly improved (p\u2009<\u20090.01), with approximately 80% of patients classified as Rutherford class 0 or 1 at 2\u00a0years.ConclusionDespite more challenging lesion characteristics, 2-year results from the current study are similar to outcomes from the previous Zilver PTX studies, confirming the efficacy of the Zilver PTX DES in a complicated femoropopliteal lesion (Zilver PTX Post-Market Study in Japan; NCT02254837).Level of EvidencePost-market surveillance study, Level III.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00270-018-2110-1", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.6836229", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.6822252", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1091062", 
        "issn": [
          "0174-1551", 
          "1432-086X"
        ], 
        "name": "CardioVascular and Interventional Radiology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "42"
      }
    ], 
    "keywords": [
      "target lesion revascularization", 
      "post-marketing surveillance study", 
      "surveillance study", 
      "femoropopliteal lesions", 
      "clinical benefit", 
      "multicenter post-marketing surveillance study", 
      "femoropopliteal artery lesions", 
      "recurrent clinical symptoms", 
      "peripheral arterial disease", 
      "chronic kidney disease", 
      "primary patency rate", 
      "femoropopliteal artery disease", 
      "critical limb ischemia", 
      "real-world patients", 
      "consecutive symptomatic patients", 
      "standard of care", 
      "lesion revascularization", 
      "numerous comorbidities", 
      "eligible patients", 
      "Rutherford classification", 
      "ischemic symptoms", 
      "artery lesions", 
      "symptomatic patients", 
      "limb ischemia", 
      "artery disease", 
      "arterial disease", 
      "diameter stenosis", 
      "clinical symptoms", 
      "duplex ultrasound", 
      "kidney disease", 
      "total occlusion", 
      "patency rates", 
      "lesion characteristics", 
      "exclusion criteria", 
      "stent restenosis", 
      "high incidence", 
      "patients", 
      "level III", 
      "lesions", 
      "disease", 
      "two years", 
      "symptoms", 
      "average length", 
      "current study", 
      "reintervention", 
      "revascularization", 
      "comorbidities", 
      "stenosis", 
      "ischemia", 
      "patency", 
      "diabetes", 
      "ConclusionDespite", 
      "restenosis", 
      "MethodsThere", 
      "years", 
      "study", 
      "incidence", 
      "physicians", 
      "ResultsIn", 
      "stents", 
      "paclitaxel", 
      "care", 
      "occlusion", 
      "efficacy", 
      "PurposeAs", 
      "ultrasound", 
      "outcomes", 
      "class 0", 
      "DES", 
      "benefits", 
      "safety", 
      "levels", 
      "Japan", 
      "criteria", 
      "rate", 
      "results", 
      "institutions", 
      "classification", 
      "effectiveness", 
      "standards", 
      "length", 
      "characteristics", 
      "freedom"
    ], 
    "name": "Zilver PTX Post-market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 2-Year Results", 
    "pagination": "358-364", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1109785132"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00270-018-2110-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30411151"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00270-018-2110-1", 
      "https://app.dimensions.ai/details/publication/pub.1109785132"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T16:02", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_795.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00270-018-2110-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00270-018-2110-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00270-018-2110-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00270-018-2110-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00270-018-2110-1'


 

This table displays all metadata directly associated to this object as RDF triples.

311 TRIPLES      21 PREDICATES      126 URIs      116 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00270-018-2110-1 schema:about N18db1a5093ad4b8284cb6fbe5755cebc
2 N2652a7caf6914a8a9177fa37d34a6691
3 N5dc5a23f5e2448f7b7f65d436fa8e03d
4 N6defb3d6f9724edbb1e4fcb4f24a2061
5 N7e08726a94b04b9ea8cd48b0959d7826
6 N875289d5462d4e43aa62822e1cc54e78
7 N9162642f0ade49e6b7a496d768725ec8
8 N926d4ccf76364b498feb96d9b2f5f24c
9 Na53d8015afd343aaa747bdb3c32bdefb
10 Nad26b4e7f8c24ac49fb01e3bfdd6ca02
11 Nae2d6ef9b2814c9691fca7cff04e31d0
12 Nba234a53d4074cb2b27b5a8bceb0dda7
13 Nbc0f3e9e31e047279278409317055422
14 Nbfbc156e365a45da831f2070bc19e22c
15 Nd9dab7a64f7b453bb02541d6ebe2cde1
16 Ne7100728798f466fa77bde242f93ef24
17 anzsrc-for:11
18 anzsrc-for:1103
19 schema:author N0ec71816ee134cc08650cf662f5d968e
20 schema:citation sg:pub.10.1007/s00270-017-1673-6
21 sg:pub.10.1007/s12928-014-0287-z
22 schema:datePublished 2018-11-08
23 schema:datePublishedReg 2018-11-08
24 schema:description PurposeA prospective, multicenter post-market surveillance study in Japan evaluated the 2-year safety and effectiveness of the DES in real-world patients with complex femoropopliteal artery lesions.MethodsThere were no exclusion criteria, and consecutive symptomatic patients with femoropopliteal lesions treated with the DES were enrolled in the study. Clinically driven target lesion revascularization (TLR) was defined as reintervention performed for > 50% diameter stenosis after recurrent clinical symptoms of peripheral arterial disease. Clinical benefit was defined as freedom from persistent or deteriorating ischemic symptoms. Patency was evaluated by duplex ultrasound where physicians considered this standard of care.ResultsIn this study, 905 patients were enrolled at 95 institutions in Japan. There were numerous comorbidities including a high incidence of diabetes (58.8%) and chronic kidney disease (43.6%). Additionally, 21.4% of patients were classified with critical limb ischemia. Lesions were complex, with an average length of 14.6 ± 9.6 cm (range 0.5–40 cm), 41.5% total occlusions, and 18.7% in-stent restenosis. In total, 1861 DES were placed in 1080 lesions. Two-year follow-up was obtained for > 90% of eligible patients. Freedom from TLR was 83.7%, and clinical benefit was 80.0% through 2 years. The 2-year primary patency rate was 70.3%. Rutherford classification significantly improved (p < 0.01), with approximately 80% of patients classified as Rutherford class 0 or 1 at 2 years.ConclusionDespite more challenging lesion characteristics, 2-year results from the current study are similar to outcomes from the previous Zilver PTX studies, confirming the efficacy of the Zilver PTX DES in a complicated femoropopliteal lesion (Zilver PTX Post-Market Study in Japan; NCT02254837).Level of EvidencePost-market surveillance study, Level III.
25 schema:genre article
26 schema:isAccessibleForFree true
27 schema:isPartOf N83da9e40e5eb4972b2f4117a4e7e7930
28 Ne8f9ed10aa444369a82a717fe72e23b3
29 sg:journal.1091062
30 schema:keywords ConclusionDespite
31 DES
32 Japan
33 MethodsThere
34 PurposeAs
35 ResultsIn
36 Rutherford classification
37 arterial disease
38 artery disease
39 artery lesions
40 average length
41 benefits
42 care
43 characteristics
44 chronic kidney disease
45 class 0
46 classification
47 clinical benefit
48 clinical symptoms
49 comorbidities
50 consecutive symptomatic patients
51 criteria
52 critical limb ischemia
53 current study
54 diabetes
55 diameter stenosis
56 disease
57 duplex ultrasound
58 effectiveness
59 efficacy
60 eligible patients
61 exclusion criteria
62 femoropopliteal artery disease
63 femoropopliteal artery lesions
64 femoropopliteal lesions
65 freedom
66 high incidence
67 incidence
68 institutions
69 ischemia
70 ischemic symptoms
71 kidney disease
72 length
73 lesion characteristics
74 lesion revascularization
75 lesions
76 level III
77 levels
78 limb ischemia
79 multicenter post-marketing surveillance study
80 numerous comorbidities
81 occlusion
82 outcomes
83 paclitaxel
84 patency
85 patency rates
86 patients
87 peripheral arterial disease
88 physicians
89 post-marketing surveillance study
90 primary patency rate
91 rate
92 real-world patients
93 recurrent clinical symptoms
94 reintervention
95 restenosis
96 results
97 revascularization
98 safety
99 standard of care
100 standards
101 stenosis
102 stent restenosis
103 stents
104 study
105 surveillance study
106 symptomatic patients
107 symptoms
108 target lesion revascularization
109 total occlusion
110 two years
111 ultrasound
112 years
113 schema:name Zilver PTX Post-market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 2-Year Results
114 schema:pagination 358-364
115 schema:productId N25dcb4c287f24435b4d0fb74ae474bde
116 N323b56b10dc94134924517007b53e4cb
117 Nb314849751464617a2c228c96e6c1730
118 schema:sameAs https://app.dimensions.ai/details/publication/pub.1109785132
119 https://doi.org/10.1007/s00270-018-2110-1
120 schema:sdDatePublished 2022-09-02T16:02
121 schema:sdLicense https://scigraph.springernature.com/explorer/license/
122 schema:sdPublisher Nfa22494e2ece4d03ab1263c3553379a2
123 schema:url https://doi.org/10.1007/s00270-018-2110-1
124 sgo:license sg:explorer/license/
125 sgo:sdDataset articles
126 rdf:type schema:ScholarlyArticle
127 N0ec71816ee134cc08650cf662f5d968e rdf:first sg:person.0745745646.46
128 rdf:rest N5840c4b309e34e5ea481dc2b6385ff14
129 N129b8a1283ac42a1a2f489f17006b0c8 rdf:first sg:person.0672625424.38
130 rdf:rest N8fd0037268bf4a7aab8638060e17bb62
131 N1320a05af6a648d38cc3c57b0e8422a3 rdf:first sg:person.0624512224.57
132 rdf:rest N785b1fd2ef934bee8de0a413413396c1
133 N18db1a5093ad4b8284cb6fbe5755cebc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Vascular Patency
135 rdf:type schema:DefinedTerm
136 N1d6fcbde9b224cee88840e98668b7ea2 rdf:first sg:person.01311264335.91
137 rdf:rest N129b8a1283ac42a1a2f489f17006b0c8
138 N25dcb4c287f24435b4d0fb74ae474bde schema:name doi
139 schema:value 10.1007/s00270-018-2110-1
140 rdf:type schema:PropertyValue
141 N2652a7caf6914a8a9177fa37d34a6691 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Ultrasonography, Doppler, Duplex
143 rdf:type schema:DefinedTerm
144 N323b56b10dc94134924517007b53e4cb schema:name pubmed_id
145 schema:value 30411151
146 rdf:type schema:PropertyValue
147 N4802458869544d079ea8000109d2a181 rdf:first sg:person.01271562423.60
148 rdf:rest N1d6fcbde9b224cee88840e98668b7ea2
149 N5840c4b309e34e5ea481dc2b6385ff14 rdf:first sg:person.01322045470.25
150 rdf:rest N75dda367f1c84f91b68b8ca156e039f4
151 N5dc5a23f5e2448f7b7f65d436fa8e03d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Japan
153 rdf:type schema:DefinedTerm
154 N6defb3d6f9724edbb1e4fcb4f24a2061 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Popliteal Artery
156 rdf:type schema:DefinedTerm
157 N75dda367f1c84f91b68b8ca156e039f4 rdf:first sg:person.01052603744.16
158 rdf:rest N8574115fe45a489094e81a04bfc4fa5a
159 N785b1fd2ef934bee8de0a413413396c1 rdf:first sg:person.0641462234.03
160 rdf:rest rdf:nil
161 N7e08726a94b04b9ea8cd48b0959d7826 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Treatment Outcome
163 rdf:type schema:DefinedTerm
164 N83da9e40e5eb4972b2f4117a4e7e7930 schema:volumeNumber 42
165 rdf:type schema:PublicationVolume
166 N8574115fe45a489094e81a04bfc4fa5a rdf:first sg:person.0623364450.95
167 rdf:rest N8bedcdae371c4694be138870e7912d94
168 N875289d5462d4e43aa62822e1cc54e78 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Femoral Artery
170 rdf:type schema:DefinedTerm
171 N8bedcdae371c4694be138870e7912d94 rdf:first sg:person.01031752616.54
172 rdf:rest N4802458869544d079ea8000109d2a181
173 N8fd0037268bf4a7aab8638060e17bb62 rdf:first sg:person.01074671261.78
174 rdf:rest N1320a05af6a648d38cc3c57b0e8422a3
175 N9162642f0ade49e6b7a496d768725ec8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Prospective Studies
177 rdf:type schema:DefinedTerm
178 N926d4ccf76364b498feb96d9b2f5f24c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Paclitaxel
180 rdf:type schema:DefinedTerm
181 Na53d8015afd343aaa747bdb3c32bdefb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Humans
183 rdf:type schema:DefinedTerm
184 Nad26b4e7f8c24ac49fb01e3bfdd6ca02 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Male
186 rdf:type schema:DefinedTerm
187 Nae2d6ef9b2814c9691fca7cff04e31d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Aged
189 rdf:type schema:DefinedTerm
190 Nb314849751464617a2c228c96e6c1730 schema:name dimensions_id
191 schema:value pub.1109785132
192 rdf:type schema:PropertyValue
193 Nba234a53d4074cb2b27b5a8bceb0dda7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Tubulin Modulators
195 rdf:type schema:DefinedTerm
196 Nbc0f3e9e31e047279278409317055422 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Drug-Eluting Stents
198 rdf:type schema:DefinedTerm
199 Nbfbc156e365a45da831f2070bc19e22c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Female
201 rdf:type schema:DefinedTerm
202 Nd9dab7a64f7b453bb02541d6ebe2cde1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
203 schema:name Peripheral Arterial Disease
204 rdf:type schema:DefinedTerm
205 Ne7100728798f466fa77bde242f93ef24 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Time Factors
207 rdf:type schema:DefinedTerm
208 Ne8f9ed10aa444369a82a717fe72e23b3 schema:issueNumber 3
209 rdf:type schema:PublicationIssue
210 Nfa22494e2ece4d03ab1263c3553379a2 schema:name Springer Nature - SN SciGraph project
211 rdf:type schema:Organization
212 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
213 schema:name Medical and Health Sciences
214 rdf:type schema:DefinedTerm
215 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
216 schema:name Clinical Sciences
217 rdf:type schema:DefinedTerm
218 sg:grant.6822252 http://pending.schema.org/fundedItem sg:pub.10.1007/s00270-018-2110-1
219 rdf:type schema:MonetaryGrant
220 sg:grant.6836229 http://pending.schema.org/fundedItem sg:pub.10.1007/s00270-018-2110-1
221 rdf:type schema:MonetaryGrant
222 sg:journal.1091062 schema:issn 0174-1551
223 1432-086X
224 schema:name CardioVascular and Interventional Radiology
225 schema:publisher Springer Nature
226 rdf:type schema:Periodical
227 sg:person.01031752616.54 schema:affiliation grid-institutes:grid.265050.4
228 schema:familyName Nakamura
229 schema:givenName Masato
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031752616.54
231 rdf:type schema:Person
232 sg:person.01052603744.16 schema:affiliation grid-institutes:None
233 schema:familyName Yokoi
234 schema:givenName Hiroyoshi
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01052603744.16
236 rdf:type schema:Person
237 sg:person.01074671261.78 schema:affiliation grid-institutes:grid.510407.7
238 schema:familyName Lottes
239 schema:givenName Aaron E.
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01074671261.78
241 rdf:type schema:Person
242 sg:person.01271562423.60 schema:affiliation grid-institutes:grid.27476.30
243 schema:familyName Komori
244 schema:givenName Kimihiro
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271562423.60
246 rdf:type schema:Person
247 sg:person.01311264335.91 schema:affiliation grid-institutes:grid.416305.5
248 schema:familyName Nanto
249 schema:givenName Shinsuke
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311264335.91
251 rdf:type schema:Person
252 sg:person.01322045470.25 schema:affiliation grid-institutes:grid.410814.8
253 schema:familyName Ichihashi
254 schema:givenName Shigeo
255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322045470.25
256 rdf:type schema:Person
257 sg:person.0623364450.95 schema:affiliation grid-institutes:grid.470100.2
258 schema:familyName Ohki
259 schema:givenName Takao
260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623364450.95
261 rdf:type schema:Person
262 sg:person.0624512224.57 schema:affiliation grid-institutes:grid.510407.7
263 schema:familyName Snyder
264 schema:givenName Scott A.
265 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624512224.57
266 rdf:type schema:Person
267 sg:person.0641462234.03 schema:affiliation grid-institutes:grid.240952.8
268 schema:familyName Dake
269 schema:givenName Michael D.
270 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0641462234.03
271 rdf:type schema:Person
272 sg:person.0672625424.38 schema:affiliation grid-institutes:grid.510407.7
273 schema:familyName O’Leary
274 schema:givenName Erin E.
275 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0672625424.38
276 rdf:type schema:Person
277 sg:person.0745745646.46 schema:affiliation grid-institutes:grid.410814.8
278 schema:familyName Kichikawa
279 schema:givenName Kimihiko
280 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0745745646.46
281 rdf:type schema:Person
282 sg:pub.10.1007/s00270-017-1673-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085377186
283 https://doi.org/10.1007/s00270-017-1673-6
284 rdf:type schema:CreativeWork
285 sg:pub.10.1007/s12928-014-0287-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1005096819
286 https://doi.org/10.1007/s12928-014-0287-z
287 rdf:type schema:CreativeWork
288 grid-institutes:None schema:alternateName Department of Cardiovascular Medicine, Fukuoka Sanno Hospital, Fukuoka, Japan
289 schema:name Department of Cardiovascular Medicine, Fukuoka Sanno Hospital, Fukuoka, Japan
290 rdf:type schema:Organization
291 grid-institutes:grid.240952.8 schema:alternateName Department of Cardiothoracic Surgery, Stanford University Medical Center, Stanford, CA, USA
292 schema:name Department of Cardiothoracic Surgery, Stanford University Medical Center, Stanford, CA, USA
293 rdf:type schema:Organization
294 grid-institutes:grid.265050.4 schema:alternateName Division of Cardiovascular Medicine, Ohashi Medical Center, Toho University, Tokyo, Japan
295 schema:name Division of Cardiovascular Medicine, Ohashi Medical Center, Toho University, Tokyo, Japan
296 rdf:type schema:Organization
297 grid-institutes:grid.27476.30 schema:alternateName Division of Vascular Surgery, Division of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan
298 schema:name Division of Vascular Surgery, Division of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan
299 rdf:type schema:Organization
300 grid-institutes:grid.410814.8 schema:alternateName Department of Radiology, Nara Medical University, Kashihara, Japan
301 schema:name Department of Radiology, Nara Medical University, Kashihara, Japan
302 rdf:type schema:Organization
303 grid-institutes:grid.416305.5 schema:alternateName Nishinomiya Hospital Affairs, Nishinomiya Municipal Central Hospital, Nishinomiya, Japan
304 schema:name Nishinomiya Hospital Affairs, Nishinomiya Municipal Central Hospital, Nishinomiya, Japan
305 rdf:type schema:Organization
306 grid-institutes:grid.470100.2 schema:alternateName Department of Surgery, Jikei University Hospital, Tokyo, Japan
307 schema:name Department of Surgery, Jikei University Hospital, Tokyo, Japan
308 rdf:type schema:Organization
309 grid-institutes:grid.510407.7 schema:alternateName Cook Research Incorporated, West Lafayette, IN, USA
310 schema:name Cook Research Incorporated, West Lafayette, IN, USA
311 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...